Dai-ichi Karkaria Ltd
Incorporated in 1963, Dai-ichi Karkaria Ltd
is in the business of manufacture and sale
of Specialty chemicals[1]
- Market Cap ₹ 293 Cr.
- Current Price ₹ 393
- High / Low ₹ 799 / 365
- Stock P/E 308
- Book Value ₹ 213
- Dividend Yield 0.51 %
- ROCE 1.63 %
- ROE -0.28 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.34% over past five years.
- Company has a low return on equity of -2.51% over last 3 years.
- Earnings include an other income of Rs.3.70 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
81 | 108 | 102 | 116 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 132 | 139 | |
78 | 100 | 94 | 101 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 130 | |
Operating Profit | 2 | 8 | 8 | 15 | 17 | 15 | -11 | -5 | -14 | -18 | 16 | 6 | 9 |
OPM % | 3% | 7% | 8% | 13% | 14% | 10% | -12% | -4% | -14% | -15% | 9% | 5% | 6% |
5 | 10 | 15 | 9 | 12 | 6 | 2 | -1 | 88 | 10 | 17 | 27 | 4 | |
Interest | 0 | 0 | 0 | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 |
Depreciation | 1 | 2 | 4 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 |
Profit before tax | 6 | 15 | 19 | 21 | 27 | 16 | -24 | -25 | 57 | -17 | 22 | 21 | 1 |
Tax % | 22% | 19% | 22% | 26% | 24% | 27% | -48% | 0% | 13% | 0% | 16% | 23% | |
4 | 13 | 15 | 16 | 21 | 12 | -13 | -25 | 50 | -17 | 18 | 16 | 1 | |
EPS in Rs | 5.89 | 16.79 | 19.84 | 20.91 | 28.04 | 16.08 | -16.95 | -33.47 | 66.82 | -22.25 | 24.79 | 21.43 | 1.27 |
Dividend Payout % | 42% | 15% | 13% | 14% | 11% | 16% | -15% | -7% | 4% | 0% | 16% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | 7% |
3 Years: | 11% |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 26% |
TTM: | -79% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 7% |
3 Years: | 3% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | -8% |
3 Years: | -3% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | 60 | 70 | 83 | 96 | 122 | 131 | 116 | 91 | 141 | 122 | 140 | 153 | 151 |
1 | 1 | 1 | 1 | 4 | 77 | 104 | 108 | 20 | 22 | 38 | 19 | 19 | |
17 | 19 | 17 | 15 | 25 | 41 | 35 | 42 | 48 | 43 | 39 | 23 | 28 | |
Total Liabilities | 85 | 98 | 108 | 119 | 158 | 256 | 262 | 249 | 217 | 194 | 225 | 202 | 206 |
16 | 15 | 14 | 16 | 20 | 94 | 164 | 153 | 105 | 105 | 139 | 132 | 131 | |
CWIP | 6 | 7 | 6 | 14 | 32 | 43 | 5 | 3 | 0 | 2 | 0 | 2 | 0 |
Investments | 20 | 31 | 42 | 40 | 44 | 21 | 5 | 2 | 5 | 1 | 1 | 1 | 1 |
44 | 45 | 46 | 49 | 62 | 98 | 88 | 92 | 107 | 86 | 85 | 67 | 74 | |
Total Assets | 85 | 98 | 108 | 119 | 158 | 256 | 262 | 249 | 217 | 194 | 225 | 202 | 206 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2 | 2 | 1 | 7 | 3 | -8 | 6 | 1 | -22 | -3 | 23 | 8 | |
8 | -2 | 2 | -3 | -7 | -57 | -21 | 1 | 130 | -4 | -33 | 18 | |
-2 | -2 | -2 | -5 | 2 | 66 | 16 | -6 | -97 | -2 | 13 | -25 | |
Net Cash Flow | 4 | -2 | 1 | -1 | -2 | 2 | 1 | -4 | 11 | -10 | 4 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 67 | 68 | 65 | 58 | 59 | 75 | 65 | 70 | 89 | 53 | 53 | 62 |
Inventory Days | 67 | 51 | 63 | 63 | 78 | 74 | 98 | 104 | 133 | 93 | 59 | 77 |
Days Payable | 54 | 45 | 54 | 52 | 68 | 83 | 128 | 146 | 210 | 122 | 87 | 74 |
Cash Conversion Cycle | 81 | 74 | 74 | 69 | 70 | 66 | 36 | 28 | 11 | 24 | 25 | 65 |
Working Capital Days | 62 | 53 | 62 | 68 | 67 | 79 | 47 | 42 | 103 | 66 | 46 | 70 |
ROCE % | 7% | 12% | 11% | 22% | 20% | 9% | -7% | -5% | -8% | -12% | 9% | 2% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 7 Nov
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 30 Oct
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 Oct - Newspaper publications for extract of unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2024.
-
Results Presentation For The Period Ended September 30, 2024
23 Oct - Results presentation for Q2 FY24-25.
-
Outcome Of Board Meeting Held On October 23, 2024
23 Oct - Approval of unaudited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is ISO 9001 certified and
in the business of development and manufacture of high-performance
specialty chemicals for various
applications. It has technical
collaboration with the Dai-
ichi Kogyo Seiyaku Co.
Ltd, of Japan